AMPEL BioSolutions
PrivateLast Round
Grant
May 18, 2023
Total Funding Raised
$800,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
AMPEL BioSolutions is a biotechnology company that develops clinical genomic tests and precision medicine solutions for autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AMPEL BioSolutions Comparables
Compare AMPEL BioSolutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Progentec Diagnostics | 88% | |
| DxTerity Diagnostics | 87% | |
| Scipher Medicine | 82% |
AMPEL BioSolutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 18, 2023 | ||||
| Series A | Jan 17, 2020 |
Key People
Founding team and executive leadership
AMPEL BioSolutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Virginia Catalyst | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 38% MoM, from 2.5K to 3.5K.
- May 16, 2026
Monthly visitors increased 95% MoM, from 1.7K to 3.3K.
AMPEL BioSolutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AMPEL BioSolutions's valuation, stock price, and market status.
Is AMPEL BioSolutions a public or private company?
AMPEL BioSolutions is a private company.
What is the current stock price of AMPEL BioSolutions?
AMPEL BioSolutions is a private company with no public stock price. No recent secondary market data is available.
How much is AMPEL BioSolutions worth (valuation)?
Valuation information for AMPEL BioSolutions is not publicly available.
Can I buy AMPEL BioSolutions stock?
AMPEL BioSolutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was AMPEL BioSolutions's last funding round?
AMPEL BioSolutions's most recent funding round was Grant on May 18, 2023.
Who are the main investors in AMPEL BioSolutions?
Key investors in AMPEL BioSolutions include Virginia Catalyst.
Will AMPEL BioSolutions IPO soon?
No public IPO plans have been announced for AMPEL BioSolutions.
How can I track AMPEL BioSolutions secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AMPEL BioSolutions's secondary market activity and sign up for updates.